FluMist® (Influenza Vaccine Live, Intranasal) Cost & Distribution

Order FluMist online from one of our distributors

FluMist is sold through Distributors, not directly through MedImmune. Current distributors are listed below:

Order by Phone

  • McKesson :
    Contact your McKesson account manager
    to order FluMist, or contact our Moore
    Medical division, above.
    1-877-MCK-4FLU (877-625-4358)
  • ASD Healthcare: Learn more about ASD Healthcare arrow 1-866-281-4FLU (4358)
  • FFF Enterprises, Inc.:
    FFF Enterprises, Inc. is an authorized distributor for the 2011-2012 season. Order from FFF Enterprises, Inc. arrow 1-800-843-7477
The VCF Program graphic FluMist® (Influenza Vaccine Live, Intranasal) at School

FluMist Reimbursement Information

For specific reimbursement answers to questions about FluMist, call the MedImmune Hotline at 1-866-470-5856.

You can find additional information on reimbursement and other practice management issues at the Practice Online section of the American Academy of Pediatric Web site.

Important Safety Information

FluMist® (Influenza Vaccine Live, Intranasal) is a vaccine indicated for active immunization of individuals 2-49 years of age against influenza disease caused by influenza virus subtypes A and type B contained in the vaccine.

FluMist is contraindicated in individuals with history of hypersensitivity to eggs, egg proteins, gentamicin, gelatin or arginine or with life-threatening reactions to previous influenza vaccinations, and in children and adolescents receiving concomitant aspirin or aspirin-containing therapy.

Do not administer FluMist to children <24 months of age due to an increased risk of hospitalization and wheezing that was observed in clinical trials. FluMist should not be administered to any individual with asthma and to children <5 years of age with recurrent wheezing unless the potential benefit outweighs the potential risk. Do not administer FluMist to individuals with severe asthma or active wheezing.

If Guillain-Barré syndrome has occurred with prior influenza vaccination, the decision to give FluMist should be based on careful consideration of the potential benefits and risks. Data supporting the safety and effectiveness of FluMist administration in immunocompromised individuals are limited. FluMist should not be administered to individuals with underlying medical conditions predisposing them to wild-type influenza infection complications unless the potential benefit outweighs the potential risk. FluMist should be given to a pregnant woman only if clearly needed.

Most common adverse reactions (occurring at ≥10% in individuals receiving FluMist and at least 5% greater than in placebo) are runny nose or nasal congestion in recipients of all ages, fever >100°F in children 2-6 years of age, and sore throat in adults.

FluMist may not protect all individuals receiving the vaccine. FluMist is for intranasal administration only.

Please see accompanying complete Prescribing Information, including Patient Information [PDF PDF].